ANIK
Anika Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.49 / 10
Netural
Technical score is 4.49/10, neutral overall. MACD Death Cross signals strong bullish momentum (8.27 rating, 87.5% win). Marubozu White is bearish (1/10, 36.8% win) and RSI Overbought is neutral (4.19, 50% win). Signals are balanced.
Analysis Checks(1/3)
RSI Overbought
Score4.19/10
Win Rate50.00%
Hist. Signals10
Avg Return1.05%
Score4.19/10
Win Rate50.00%
Hist. Signals10
Avg Return1.05%
Marubozu White
Score1/10
Win Rate36.84%
Hist. Signals19
Avg Return-0.87%
Score1/10
Win Rate36.84%
Hist. Signals19
Avg Return-0.87%
MACD Death Cross
Score8.27/10
Win Rate87.50%
Hist. Signals8
Avg Return2.91%
Score8.27/10
Win Rate87.50%
Hist. Signals8
Avg Return2.91%
RSI Overbought
Score4.19/10
Win Rate50.00%
Hist. Signals10
Avg Return1.05%
Score4.19/10
Win Rate50.00%
Hist. Signals10
Avg Return1.05%
MACD Death Cross
Score8.27/10
Win Rate87.50%
Hist. Signals8
Avg Return2.91%
Score8.27/10
Win Rate87.50%
Hist. Signals8
Avg Return2.91%
Marubozu White
Score1/10
Win Rate36.84%
Hist. Signals19
Avg Return-0.87%
Score1/10
Win Rate36.84%
Hist. Signals19
Avg Return-0.87%
Technical Analysis of ANIK?
- ANIK presents a Netural setup with a Technical Score of 4.49/10. Key technical indicators highlight an RSI of 61.55 and a MACD of -0.21, with the trend anchored by the 50-Day SMA at 12.28. Traders should monitor key support at 14.60 and resistance at 15.24.
